domingo, 11 de febrero de 2024

Efficacy and safety of moxidectin compared with ivermectin against Strongyloides stercoralis infection in adults in Laos and Cambodia: a randomised, double-blind, non-inferiority, phase 2b/3 trial

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00507-8/fulltext?dgcid=hubspot_update_feature_updatealerts_laninf&utm_campaign=update-laninf&utm_medium=email&_hsmi=292975442&_hsenc=p2ANqtz-9waY_OPbm0BtIgvRWXZVKu-vn_ym5Lj2sbFLrLovNp4BRexeMtclBaBYNPnjNlr_q76eaRzNGPPzJz9AEnKAGQ0S0FJA&utm_content=292924437&utm_source=hs_email

No hay comentarios:

Publicar un comentario